GPRC5B, an obesity-related membrane protein implicated in insulin resistance, may contribute to the metabolic disturbances characteristic of type 2 diabetes mellitus (T2DM), including increased adiposity, impaired insulin secretion, and glucose intolerance [28,107]. Here, GPRC5B is linked to type 2 diabetes mellitus.